Latest news about Valiant Organics
Valiant Organics
286.70
-0.85(-0.30%)
Company Performance:
View Company Insights1D-0.30%
1M+12.64%
6M+14.06%
1Y-27.58%
5Y-82.41%
More news about Valiant Organics
09Apr 26
Valiant Organics Publishes Saksham Niveshak Campaign Notice in Major Newspapers
Valiant Organics Limited informed stock exchanges about publishing newspaper advertisements for its Second 100 Days Campaign - Saksham Niveshak in Financial Express and Mumbai Lakshadeep on April 09, 2026. The campaign, running from April 01 to July 09, 2026, aims to help shareholders claim unpaid dividends and update KYC details before transfer to IEPF.
04Apr 26
Valiant Organics Submits SEBI Compliance Certificate for Quarter Ended March 31, 2026
Valiant Organics Limited submitted its SEBI Regulation 74(5) compliance certificate for Q4 FY26 to BSE and NSE on April 04, 2026. The certificate from RTA MUFG Intime India confirms the regulation is not applicable as all company securities remain in dematerialized form with no conversion requests received during the quarter ended March 31, 2026.
24Mar 26
Valiant Organics Clarifies Recent Stock Price Movement to BSE and NSE
Valiant Organics Limited responded to BSE and NSE surveillance queries about recent stock price movements, clarifying that no undisclosed price-sensitive information exists. The company attributed the price volatility to market-driven factors and reaffirmed its commitment to timely regulatory disclosures under SEBI regulations.
25Feb 26
Valiant Organics Shares Rise on 500 Basis Points Gross Margin Expansion to 43%
Valiant Organics shares gained momentum after reporting significant margin improvements in Q3FY26 results. The specialty chemicals manufacturer achieved a remarkable 500 basis points expansion in gross margin to 43% and maintained EBITDA margin at 11.82% for nine months. Despite Q3FY26 revenue declining to INR 1,593 Mn, the company demonstrated strong operational efficiency with nine-month revenue of INR 5,210 Mn and 84.4% EBITDA growth, marking a successful turnaround from previous year's losses.
13Feb 26
Valiant Organics Reports Strong Q3FY26 Results with ₹606.36 Lakhs Net Profit
Valiant Organics Limited announced strong Q3FY26 results with net profit of ₹606.36 lakhs, representing 30.52% growth despite revenue decline. The company achieved remarkable nine-month turnaround with ₹1,923.82 lakhs profit versus previous year's loss, aided by ₹572.08 lakhs exceptional gain from fire insurance settlement.
26Sept 25
Valiant Organics Shareholders Approve Key Appointments and Secretarial Auditor at 20th AGM
Valiant Organics Limited held its 20th AGM on September 26, approving several important resolutions. Shareholders re-appointed Shri Mahek M. Chheda as Executive Director and Shri Kiritkumar H. Desai as Non-Executive Director. M/s Mehta & Mehta was appointed as the new Secretarial Auditor for five years. The company reported an operating revenue of 719.00 crore for FY 2024-25 with an EBITDA margin of 7.47%. Other approvals included remuneration for the Managing Director and Cost Auditor, and material related party transactions.
20Aug 25
Valiant Organics Reports Strong Q1 Recovery with 58% EBITDA Growth
Valiant Organics, a specialty chemicals manufacturer, reported impressive Q1 results. Revenue from operations grew 21.7% year-on-year to INR 2,044.00 million. Operating EBITDA surged 58% to INR 248.00 million, with EBITDA margins expanding by 278 basis points to 12.13%. The company turned profitable with a PAT of INR 82.00 million, compared to a loss in the previous year. Hydrogenation segment was the largest revenue contributor at 53%. The company maintains a strong financial position with a net worth of INR 5,698.00 million and a net debt to equity ratio of 0.33.
15Aug 25
Valiant Organics Reports 22% Revenue Growth and Significant Profit Surge in Q1
Valiant Organics posted consolidated revenue of Rs 205.48 crore, up 22% year-over-year. Net profit surged to Rs 8.20 crore from Rs 0.62 crore. EBITDA rose 53% to Rs 19.75 crore, with margin improving to 9.60%. EPS increased to Rs 2.93 from Rs 0.23. Management projects 15-20% revenue growth for the full year with EBITDA margins of 10-12%. The company plans capital expenditure of Rs 100-120 crore for capacity expansion and new product development.
19Jun 25
Valiant Organics to Explore Fundraising Options in Upcoming Board Meeting
Valiant Organics Limited, a key player in the chemical industry, has announced a board meeting scheduled for June 25 to discuss and consider various fundraising options. This move could potentially impact the company's future growth strategies and financial structure. The specific details of the fundraising options have not been disclosed, but the decision could influence the company's stock performance and long-term prospects.
12Jun 25
Valiant Organics Withdraws ₹500 Million Rights Issue Citing Regulatory Changes
Valiant Organics Limited has withdrawn its proposed ₹500 million rights issue, citing unspecified regulatory changes as the reason. The decision impacts the company's capital raising strategy and maintains its current capital structure. The move reflects the company's cautious approach to compliance with evolving financial regulations in India. Shareholders and investors are advised to watch for alternative capital raising plans or strategic moves from the company.
Industry Peers
Pidilite Industries
SRF
Gujarat Fluorochemicals
Navin Fluorine International
Himadri Speciality Chemical
Deepak Nitrite
Atul
Aarti Industries
Anupam Rasayan
BASF
1,478.50
(+0.09%)
2,749.70
(+1.43%)
3,784.20
(-1.26%)
7,396.00
(-0.66%)
606.40
(+2.22%)
1,727.10
(-1.08%)
7,018.00
(-0.31%)
491.00
(+1.74%)
1,370.30
(-0.06%)
3,491.40
(-0.67%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
